Table 4.
Continence status and Patient Perception of Bladder Condition (PPBC)
| Type of bladder dysfunction | Incontinence1 events / day, mean (SD) | PPBC score2 mean (SD) | ||
|---|---|---|---|---|
| Before | After | Before | After | |
| Neurogenic | 3.7 (0.9) | 0.5 (0.8) | 4.9 (0.5) | 2.0 (0.8) |
| Non-neurogenic | 3.4 (0.6) | 0.3 (0.3) | 5.0 (0.6) | 1.7 (0.6) |
| All | 3.6 (0.7) | 0.4 (0.6) | 5.0 (0.6) | 1.8 (0.7) |
SD: standard deviation. Before: Mean number of incontinence episodes per day on 3-day voiding diary when initiating study. After: Mean number of incontinence episodes per day on 3-day voiding diary at last follow-up. PPBC: Patient perception of Bladder Condition (scale 1 to 6).
1
The number of incontinence episodes per day was significantly decreased during anticholinergic combination therapy; overall, neurogenic and non-neurogenic patients (p < 0.0001).
2
PPBC scores significantly decreased from start to end of study; overall, neurogenic and non-neurogenic groups (p < 0.0001).